Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Total Liabilities (2023 - 2025)

Camp4 Therapeutics' Total Liabilities history spans 3 years, with the latest figure at -$47.7 million for Q4 2025.

  • For Q4 2025, Total Liabilities fell 414.61% year-over-year to -$47.7 million; the TTM value through Dec 2025 reached -$47.7 million, down 414.61%, while the annual FY2025 figure was -$47.7 million, 414.61% down from the prior year.
  • Total Liabilities for Q4 2025 was -$47.7 million at Camp4 Therapeutics, down from $27.7 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $147.1 million in Q2 2024 and bottomed at -$51.6 million in Q1 2025.
  • The 3-year median for Total Liabilities is $17.4 million (2023), against an average of $33.2 million.
  • The largest YoY upside for Total Liabilities was 52.42% in 2025 against a maximum downside of 414.61% in 2025.
  • A 3-year view of Total Liabilities shows it stood at $16.5 million in 2023, then dropped by 8.26% to $15.2 million in 2024, then plummeted by 414.61% to -$47.7 million in 2025.
  • Per Business Quant, the three most recent readings for CAMP's Total Liabilities are -$47.7 million (Q4 2025), $27.7 million (Q3 2025), and -$40.0 million (Q2 2025).